815WORKSHOP V
INTRAUTERINE INFLAMMATION AND INFECTION
Chair: S. Andersson, Helsinki, Finland; W.S. Park, Seoul, Korea
• Intrauterine inflammation and possible consequences for the preterm infant
B.W. Kramer, Maastricht, The Netherlands
• Ureaplasma species: The hidden danger for preterm infants
K. Glaser, Würzburg, Germany
• Fungal infections in the NICU: Preventive and therapeutic strategies
E. Özek, Istanbul, Turkey
945Interactive Discussion
1015Coffee Break
1045WORKSHOP VI
THE NEONATAL IMMUNE SYSTEM AND IMMUNODEFICIENCIES
Chair: B.W. Kramer, Maastricht, The Netherlands; B. Thébaud, Ottawa, Canada
• Modulation of the immune-microbiome interplay - any benefit for the newborn?
C. Härtel, Würzburg, Germany
• When mother’s antibodies attack the neonate
C. Bührer, Berlin, Germany
• Rare but dangerous: Immunodeficiencies of the newborn
H. Morbach, Würzburg, Germany
1215Interactive Discussion
1245Lunch Break
1300Poster Session___
I RESPIRATORY CARE, PULMONARY DISEASES AND BPD – Part 1
Chair: A.B. te Pas, Leiden, The Netherlands; J.M. Solano, Bogota, Colombia
II NUTRITION / GROWTH
Chair: C. Härtel, Würzburg, Germany; William W. Hay Jr., Denver, USA
III BRAIN AND NEURODEVELOPMENTAL OUTCOME
Chair: C. Bührer, Berlin, Germany; N. Marlow, London, UK
1400WORKSHOP VII
STRATEGIES FOR A SUCCESSFUL FEEDING
Chair: W.W. Hay Jr., Denver, USA; I. Iskander, Cairo, Egypt
• Parenteral nutrition for immature preterm infants in the first week of life and beyond:
Fluid intake, electrolytes and energy supply
W.W. Hay Jr., Denver, USA
• Do we need fortifiers and nutritional supplements for preterm infants?
N. Modi, London, UK
• Strategies for a successful feeding of the premature baby
A. Liubsys, Vilnius, Lithuania
1530Interactive Discussion
1600Coffee Break
1630WORKSHOP VIII
PAIN, SEIZURES AND ROP
Chair: N. Marlow, London, UK; J.M. Solano, Bogota, Colombia
• Is there a way to measure pain perception in preterm infants?
R. Slater, Oxford, UK
• The role of aEEg in seizure identification and prediction of outcome
L.S. de Vries, Utrecht, The Netherlands
• Growth factors and Anti-VEGF in severe ROP: Has the time come?
A. Hellström, Gothenburg, Sweden
1800Interactive Discussion
1830Parallel Seminars___
A How to get your manuscript rejected?
E.S. Shinwell, Tsfat, Israel
B How to design a clinical trial: From basics to pitfalls
N. Modi, London, UK
C Neonatal clinical pharmacology:
A delicate combination of developmental biology and genetics
J.N. van den Anker, Washington D.C., USA
1915Adjourn